roxindole
SMILES | Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 |
InChIKey | HGEYJZMMUGWEOT-UHFFFAOYSA-N |
Chemical properties
Hydrogen bond acceptors | 2 |
Hydrogen bond donors | 2 |
Rotatable bonds | 6 |
Molecular weight (Da) | 346.2 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | No |
Database connections
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 9.4 | 9.65 | 9.9 | Guide to Pharmacology |
5-HT1B | 5HT1B | Human | 5-Hydroxytryptamine | A | pKi | 5.8 | 5.9 | 6.0 | Guide to Pharmacology |
5-HT1D | 5HT1D | Human | 5-Hydroxytryptamine | A | pKi | 7.0 | 7.1 | 7.2 | Guide to Pharmacology |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 8.2 | 8.2 | 8.2 | Guide to Pharmacology |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 7.5 | 7.5 | 7.5 | Guide to Pharmacology |
α1A | ADA1A | Human | Adrenoceptors | A | pKi | 8.6 | 8.6 | 8.6 | Guide to Pharmacology |
α2B | ADA2B | Human | Adrenoceptors | A | pKi | 8.3 | 8.3 | 8.3 | Guide to Pharmacology |
α2C | ADA2C | Human | Adrenoceptors | A | pKi | 8.8 | 8.8 | 8.8 | Guide to Pharmacology |
D2 | DRD2 | Human | Dopamine | A | pKi | 8.6 | 8.6 | 8.6 | Guide to Pharmacology |
D3 | DRD3 | Human | Dopamine | A | pKi | 8.9 | 8.9 | 8.9 | Guide to Pharmacology |
D4 | DRD4 | Human | Dopamine | A | pKi | 8.2 | 8.2 | 8.2 | Guide to Pharmacology |
D2 | DRD2 | Rat | Dopamine | A | pKi | 7.85 | 8.32 | 9.06 | ChEMBL |
D4 | DRD4 | Human | Dopamine | A | pKi | 7.62 | 7.62 | 7.62 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pKi | 8.36 | 8.46 | 8.55 | PDSP Ki database |
α1B | ADA1B | Human | Adrenoceptors | A | pKi | 8.55 | 8.55 | 8.55 | PDSP Ki database |
α1D | ADA1D | Human | Adrenoceptors | A | pKi | 8.59 | 8.73 | 8.87 | PDSP Ki database |
D1 | DRD1 | Human | Dopamine | A | pKi | 6.33 | 6.33 | 6.33 | PDSP Ki database |
D3 | DRD3 | Human | Dopamine | A | pKi | 8.93 | 8.93 | 8.93 | PDSP Ki database |
D4 | DRD4 | Human | Dopamine | A | pKi | 8.23 | 8.23 | 8.23 | PDSP Ki database |
D5 | DRD5 | Human | Dopamine | A | pKi | 6.72 | 6.72 | 6.72 | PDSP Ki database |
5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 9.94 | 9.94 | 9.94 | PDSP Ki database |
α2A | ADA2A | Human | Adrenoceptors | A | pKi | 8.21 | 8.21 | 8.21 | PDSP Ki database |
α2B | ADA2B | Human | Adrenoceptors | A | pKi | 8.34 | 8.34 | 8.34 | PDSP Ki database |
β1 | ADRB1 | Human | Adrenoceptors | A | pKi | 5.57 | 5.57 | 5.57 | PDSP Ki database |
β2 | ADRB2 | Human | Adrenoceptors | A | pKi | 6.03 | 6.03 | 6.03 | PDSP Ki database |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 8.18 | 8.18 | 8.18 | PDSP Ki database |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 7.51 | 7.51 | 7.51 | PDSP Ki database |
5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 6.51 | 6.51 | 6.51 | PDSP Ki database |
H1 | HRH1 | Guinea pig | Histamine | A | pKi | 6.89 | 6.89 | 6.89 | PDSP Ki database |
5-HT1D | 5HT1D | Human | 5-Hydroxytryptamine | A | pKi | 7.2 | 7.2 | 7.2 | PDSP Ki database |
5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 6.5 | 6.5 | 6.5 | Guide to Pharmacology |
α2C | ADA2C | Human | Adrenoceptors | A | pKi | 8.75 | 8.75 | 8.75 | PDSP Ki database |
D3 | DRD3 | Human | Dopamine | A | pKi | 9.4 | 9.4 | 9.4 | ChEMBL |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
D2 | DRD2 | Rat | Dopamine | A | pIC50 | 8.22 | 8.23 | 8.25 | ChEMBL |
5-HT1A | 5HT1A | Rat | 5-Hydroxytryptamine | A | pIC50 | 9.1 | 9.1 | 9.1 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pEC50 | 9.43 | 9.43 | 9.43 | ChEMBL |
TSH | TSHR | Human | Glycoprotein hormone | A | Potency | 4.4 | 4.4 | 4.4 | ChEMBL |
5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pIC50 | 9.1 | 9.1 | 9.1 | ChEMBL |